Based on the data collected, here's a review of your portfolio comprising Apple, Microsoft, Tesla, NVIDIA, Amazon, and Google.

Strong Diversification Within Tech

• Portfolio includes leaders across tech: cloud (MSFT, AMZN, GOOGL), hardware (AAPL), semiconductors (NVDA), AI and energy (TSLA)
• Companies have different growth drivers

Excellent Financial Performance

• Most holdings have strong gross profit margins (NVDA: 60.5%, MSFT: 68.6%, AAPL: 46.5%)
• Return on equity is solid across most holdings, with NVDA leading at 22.4%

Exposure to AI Growth

• NVDA (15% allocation) is the market leader in AI infrastructure
• MSFT, AMZN, and GOOGL have strong AI investments and cloud platforms
• Recent price action shows continued growth in AI-related companies

Weak Points

1. High Tech Concentration: 87% of your portfolio is in tech/tech-adjacent stocks with no exposure to other sectors
2. Valuation: TSLA has an extremely high P/E ratio of 162x compared to peers. NVDA, while performing well, trades at 36.7x earnings
3. Decreasing Growth: TSLA showing declining revenue growth and margin compression. AAPL revenue growth has slowed to single digits
4. Concentration: All companies are US-based with similar regulatory and economic exposure

Summary

Your portfolio's concentration in high-quality tech companies provides good exposure to growth trends like AI, cloud computing, and digital services. However, it lacks diversification beyond technology, making it vulnerable to tech-specific downturns.

Based on the financial data, I can provide you with an analysis of Oscar Health's performance compared to its peers (UnitedHealth Group, Cigna, Humana, and Centene).

Oscar Health is much smaller in size. It is approximately 1.1% the size of UnitedHealth.

• Oscar Health: $5.5 billion (Q2 2025)
• UnitedHealth (UNH): $479.1 billion (Q1 2025)
• Cigna (CI): $88.3 billion (Q2 2025)
• Humana (HUM): $29.4 billion (Q2 2025)
• Centene (CNC): $27.0 billion (Q2 2025)

Oscar Health's financial performance has been improving, as you can see in the chart below:

Oscar's revenue increased from approximately $1.47 billion in Q1 2023 to $2.86 billion in Q2 2025, representing a 94.6% growth over this period.

This outpaces the growth rate of larger peers during the same timeframe. However, its absolute revenue remains just a fraction of competitors.

The bigger concern is that Oscar has struggled with profitability compared to its peers:

• Oscar only recently achieved positive P/E ratio in Q2 2025 (42.65)
• Latest EPS was negative (-$0.97) in Q2 2025
• Return on equity is highly inconsistent and currently negative (-19.7%) in Q2 2025

Oscar has a much lower debt burden than peers, but this reflects its smaller scale:

• Oscar Health: $300 million total debt (Q2 2025)
• UnitedHealth: $81.3 billion (Q1 2025)
• Cigna: $30.8 billion (Q2 2025)
• Humana: $12.6 billion (Q2 2025)
• Centene: $17.6 billion (Q2 2025)

Oscar has shown impressive revenue growth:

• Oscar Health: ~94.6% revenue growth from Q1 2023 to Q2 2025
• UnitedHealth: ~19.2% revenue growth in the same period
• Cigna: ~44.6% revenue growth
• Humana: ~21.1% revenue growth
• Centene: ~25.3% revenue growth

Summary

Oscar Health appears to be making progress in establishing itself in the health insurance market but still faces significant challenges in achieving consistent profitability that rivals the established players. Its high growth rate is promising, but the company will need to translate this into sustainable earnings to justify its valuation.

The major indices are trading in positive territory today after yesterday's modest decline:

• SPY (S&P 500 ETF): Trading at $641.01, up 0.27% today
• QQQ (Nasdaq 100 ETF): Trading at $578.15, up 0.52% today

Crypto markets reached all-time high market capitalization:

• BTCUSD (Bitcoin): Trading at $119,879.85, currently down about 2% from yesterday
• ETHUSD (Ethereum): Trading at $4,474.50, up significantly after surpassing $4,000

1. Inflation Data Supporting Markets: The July Consumer Price Index (CPI) came in at 2.7%, below consensus estimates.
2. Intel Gaining: INTC shares are trading higher after CEO Lip-Bu Tan met with investors.
3. Trump Tariff Comments: President Trump commented on Truth Social that "Trillions of Dollars are being taken in on Tariffs".
4. Pre-Market Movers: Several stocks showing significant movement in pre-market trading include ACHR (Archer Aviation), BBAI (BigBear.ai), and MYO (Myomo, down over 42% despite revenue beat).

Overall volatility is very low, as indicated in the chart below:

Overall, here is the sector performance for this year:

Information technology continues to lead the US equity markets.

After examining your Apple stock chart and gathering additional price history data, here's a comprehensive analysis of what we're seeing:

AAPL is currently trading at $230.04, showing a relatively strong performance today with the price up from yesterday's close of $227.18. The chart reveals a multi-month descending triangle pattern that has been developing since early 2025, with recent price action showing a significant breakout attempt on high volume.

Looking at the broader price history, Apple experienced:

1. Major Volatility in April: There was an extreme price drop in early April 2025 (visible as the large bearish candles), followed by a recovery.
2. Recent Consolidation: Throughout June and July 2025, the stock consolidated between roughly $200-$215.

From your chart, AAPL appears to be making a significant technical move by breaking out of its multi-month descending triangle pattern:

• Breakout Confirmation: Will the price hold above the previous diagonal resistance (around $225-230)? A sustained move above this level would confirm the breakout.
• Volume Support: The initial breakout had strong volume support (August 8th), which is positive, but continued volume would help validate the move.
• Potential Targets: If this breakout holds, technical traders might look toward the previous highs in the $240-245 range as a potential target.
• Risk Points: A fall back below $220 would suggest a false breakout and could signal a return to the triangle support around $210-215.

The recent price action suggests increased bullish momentum, but watch for confirmation in the coming days, particularly whether the price can sustain levels above the broken trendline.

I know you asked about the chart, but I thought it was also important to add some fundamental context. Here is their annual revenue and growth rates:

Would you like me to go deeper into the technicals or the fundamentals?

Tesla's market cap has fluctuated. It is one of the few companies to tag the $1 trillion dollar mark. The bull case for Tesla goes something like this:

AI & Automation Leadership

• Leading the transition to autonomous driving
• Potential Robotaxi service launching, targeting half of US population by end of 2025
• Partnership with Samsung for AI chips ($16.5B deal)

Product Expansion

• New affordable Model Y variant in production
• Cybercab Robotaxi scheduled for production in 2026
• Optimus robot prototypes with production in 2026

Strong Analyst Support

• Multiple firms maintain "buy" ratings
• Price targets ranging from $350-515
• Viewed as "best physical AI play"

Energy Business Growth

• Energy storage business performing well
• New partnerships like Sunrun
• Lithium refining and cathode production on track for 2025

Tesla's Q2 2025 earnings showed mixed results with revenue of $22.5B (miss) and EPS of $0.40 (miss). However, Elon Musk sees potential for a $20-30 trillion valuation long-term.

The company faces near-term challenges ("a few rough quarters") but bulls are betting on Tesla's transition from a car company to an AI and robotics leader.

Based on the data collected, here's a review of your portfolio comprising Apple, Microsoft, Tesla, NVIDIA, Amazon, and Google.

Strong Diversification Within Tech

• Portfolio includes leaders across tech: cloud (MSFT, AMZN, GOOGL), hardware (AAPL), semiconductors (NVDA), AI and energy (TSLA)
• Companies have different growth drivers

Excellent Financial Performance

• Most holdings have strong gross profit margins (NVDA: 60.5%, MSFT: 68.6%, AAPL: 46.5%)
• Return on equity is solid across most holdings, with NVDA leading at 22.4%

Exposure to AI Growth

• NVDA (15% allocation) is the market leader in AI infrastructure
• MSFT, AMZN, and GOOGL have strong AI investments and cloud platforms
• Recent price action shows continued growth in AI-related companies

Weak Points

1. High Tech Concentration: 87% of your portfolio is in tech/tech-adjacent stocks with no exposure to other sectors
2. Valuation: TSLA has an extremely high P/E ratio of 162x compared to peers. NVDA, while performing well, trades at 36.7x earnings
3. Decreasing Growth: TSLA showing declining revenue growth and margin compression. AAPL revenue growth has slowed to single digits
4. Concentration: All companies are US-based with similar regulatory and economic exposure

Summary

Your portfolio's concentration in high-quality tech companies provides good exposure to growth trends like AI, cloud computing, and digital services. However, it lacks diversification beyond technology, making it vulnerable to tech-specific downturns.